The Effect of Coronavirus Outbreak on the Utilization of Coronary Revascularization Procedures: An Interrupted Time

Antonio Sarria-Santamera1, Alexandr Petrov1, Dinara Yessimova1

  • 1Department of Biomedical Sciences, Nazarbayev University School of Medicine, Nur-Sultan 010000, Kazakhstan.

Insights

The COVID-19 pandemic reduced coronary revascularization rates in Spain, increasing the risk profile for coronary artery bypass graft (CABG) patients. This trend toward higher-risk patients began before the pandemic.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • The COVID-19 pandemic significantly strained healthcare systems globally.
  • Programmed interventions like coronary revascularization were postponed, particularly during the pandemic's initial wave in Spain.
  • The exact impact of delayed coronary revascularization procedures remains unclear.

Purpose of the Study:

  • To evaluate changes in the utilization rates and patient risk profiles for percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) before and after March 2020.
  • To assess the impact of the COVID-19 pandemic's first wave on coronary revascularization procedures in Spain.

Main Methods:

  • Interrupted time series (ITS) analysis was employed.
  • Data from the Spanish National Hospital Discharge Database (SNHDD) were utilized.
  • Patient risk profiles and procedure rates for PCI and CABG were compared across pre- and post-March 2020 periods.

Main Results:

  • The first wave of COVID-19 in Spain led to a reduction in coronary revascularization cases.
  • A notable increase in the risk profile was observed for patients undergoing CABG, but not PCI.
  • A pre-existing trend of increasing patient risk profiles for both PCI and CABG was identified prior to the pandemic.

Conclusions:

  • The COVID-19 pandemic's initial impact in Spain altered coronary revascularization utilization and patient risk stratification.
  • While CABG patients showed an increased risk profile post-pandemic onset, this trend was already emerging.
  • Further research using diverse datasets and regions is recommended to validate these findings.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
27
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
43